Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.6M Sell
100,000
-20,000
-17% -$5.65M 0.12% 128
2026
Q1
$32M Sell
120,000
-47,500
-28% -$13.1M 0.2% 99
2025
Q4
$46.1M Buy
167,500
+45,000
+37% +$12.6M 0.29% 85
2025
Q3
$35.3M Buy
122,500
+32,500
+36% +$9.62M 0.25% 82
2025
Q2
$29.8M Buy
+90,000
New +$29M 0.26% 82

Other funds holding CI

Marex Group's CI Position: Q2 2026 in Review

Marex Group reduced its Cigna (CI) stake by 16% in Q2 2026, selling an estimated $5.43M and leaving 101,224 shares worth $27.9M. The position accounts for 0.12% of the portfolio, ranked #127.

Marex Group first reported a position in CI in Q4 2022 and has held it in 12 quarters since. The position peaked at $73M in Q2 2023. 1,699 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Marex Group held 101,224 shares of Cigna worth $27.9M as of Q2 2026.
  • Marex Group sold 19,220 Cigna shares in Q2 2026, an estimated $5.43M.
  • Cigna made up 0.12% of Marex Group's portfolio in Q2 2026, its #127 holding.
  • Marex Group first reported a position in Cigna in Q4 2022 and has held it in 12 quarters since.
  • Marex Group's Cigna position peaked at $73M in Q2 2023.
  • 1,699 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.